evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract,articles/18/pmid,articles/18/title,articles/18/journal,articles/18/pubDate,articles/18/volume,articles/18/issue,articles/18/pages,articles/18/authors,articles/18/elocationId,articles/18/link,articles/18/reference,articles/18/abstract,articles/19/pmid,articles/19/title,articles/19/journal,articles/19/pubDate,articles/19/volume,articles/19/issue,articles/19/pages,articles/19/authors,articles/19/elocationId,articles/19/link,articles/19/reference,articles/19/abstract,articles/20/pmid,articles/20/title,articles/20/journal,articles/20/pubDate,articles/20/volume,articles/20/issue,articles/20/pages,articles/20/authors,articles/20/elocationId,articles/20/link,articles/20/reference,articles/20/abstract,articles/21/pmid,articles/21/title,articles/21/journal,articles/21/pubDate,articles/21/volume,articles/21/issue,articles/21/pages,articles/21/authors,articles/21/elocationId,articles/21/link,articles/21/reference,articles/21/abstract
18834,GENE_SUMMARY,,SMAD2 encodes a tumor suppressor and transcription factor that is a downstream effector in the TGF-ß signal transduction pathway. SMAD2 is infrequently mutated in a diverse range of cancers.,,2017-04-07,,4087,SMAD2,SMAD family member 2,False,ENST00000262160,NM_001003652.3,hSMAD2,JV18,MADH2,MADR2,JV18-1,hMAD-2,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18835,GENE_BACKGROUND,,"The SMAD2 (SMAD family member 2) gene encodes a critical effector in the transforming growth factor beta (TGFß) signal pathway. The SMAD proteins have an N-terminal MH1 and a C-terminal MH2 domain, the former important for DNA binding and the latter for binding to regulators and effectors, including the TGFß receptors and transcription cofactors (PMID: 12821112, 25935112). SMAD2 belongs to the subgroup of receptor-regulated SMADs (R-SMADs; SMADs 1,2,3,5 and 8/9) which are phosphorylated twice at a S-S-X-S motif of the MH2 domain in response to the activation of membrane receptor serine kinases by the TGFß superfamily of cytokines (e.g. TGFß1, TGFß2, TGFß3, activin and nodal) (PMID: 25935112, 9759503). This permits formation of a SMAD trimeric complex containing two R-SMADs and SMAD4, cofactor binding and subsequent translocation to the nucleus (PMID: 9759503). Notably, SMAD2 is thought to lack DNA-binding activity itself due to an insertion in the MH1 domain in its most common splice variant (PMID: 16322555, 10708951). The SMAD complex stimulates target gene expression in a cell-type dependent manner specified, in part, by the availability of transcriptional co-activators and chromatin accessibility (PMID: 22992590). The contextual nature of TGFß-dependent transcription allows the TGFß pathway to suppress tumorigenesis in premalignant states and promote invasiveness and metastasis during cancer progression (PMID: 22992590, 18662538, 20495575). Although infrequent, SMAD2 mutations are found in colorectal cancer and less frequently in various other cancer types, such as lung and hepatocellular cancer (PMID: 23139211, 22895193, 22810696, 8752209, 8971158, 10490821, 16959974). Loss of SMAD2 expression occurs at a low frequency in colorectal, gastric and ovarian cancer and correlates with poor prognosis (PMID: 25935112, 23139211, 9679244, 8752209, 12967141, 22539990, 12894231). Notably, both elevated and decreased levels of phosphorylated SMAD2 are associated with poor prognosis in gastric, esophageal squamous cell and lung carcinomas (PMID: 21110833, 22539990, 16788944, 25373709).",,2017-04-07,,4087,SMAD2,SMAD family member 2,False,ENST00000262160,NM_001003652.3,hSMAD2,JV18,MADH2,MADR2,JV18-1,hMAD-2,True,22895193,Recurrent R-spondin fusions in colon cancer.,Nature,2018-08-30T20:12:00,488,7413,660-4,Seshagiri S et al,doi: 10.1038/nature11282,,0001-08-30,,8971158,Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers.,Cancer research,0001-12-15,56,24,5583-5,Uchida K et al,,,0001-12-15,,16322555,Smad transcription factors.,Genes &amp; development,2017-12-01T20:05:00,19,23,2783-810,Massagué J et al,,,2017-12-01T08:10:00,,10708951,The Smads: transcriptional regulation and mouse models.,Cytokine &amp; growth factor reviews,2018-03-01T20:00:00,11,2001-01-02,37-48,Datto M et al,,,2002-01-02,,10490821,Smad2 and Smad4 gene mutations in hepatocellular carcinoma.,Oncogene,0001-08-26,18,34,4879-83,Yakicier MC et al,,,0001-08-26,,22810696,Comprehensive molecular characterization of human colon and rectal cancer.,Nature,2018-07-18T20:12:00,487,7407,330-7,Cancer Genome Atlas Network.,doi: 10.1038/nature11252,,0001-07-18,,22992590,TGFβ signalling in context.,Nature reviews. Molecular cell biology,2018-10-01T20:12:00,13,10,616-30,Massagué J,doi: 10.1038/nrm3434,,0001-10-01,,25935112,Structural determinants of Smad function in TGF-β signaling.,Trends in biochemical sciences,2018-06-01T20:15:00,40,6,296-308,Macias MJ et al,doi: 10.1016/j.tibs.2015.03.012,,2018-06-01T03:08:00,,16959974,The consensus coding sequences of human breast and colorectal cancers.,"Science (New York, N.Y.)",2018-10-13T20:06:00,314,5797,268-74,Sjöblom T et al,,,0001-10-13,,9679244,TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads.,0001-01-01,0001-06-01,4,6,257-62,Hata A et al,,,0001-06-01,,12967141,Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.,"Cancer journal (Sudbury, Mass.)",2018-07-01T20:03:00,9,4,302-12,Xie W et al,,,0001-07-01,,25373709,High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer.,World journal of surgical oncology,2018-11-05T20:14:00,12,,328,Chen Y et al,doi: 10.1186/1477-7819-12-328,,0001-11-05,,22539990,Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer.,PloS one,2012,7,4,e35684,Wu Y et al,doi: 10.1371/journal.pone.0035684,,Wu Y et al. PloS one. 2012;7(4)e35684.,,9759503,TGF-beta signal transduction.,Annual review of biochemistry,1998,67,,753-91,Massagué J,,,Massagué J. Annual review of biochemistry. 1998;67()753-91.,,18662538,TGFbeta in Cancer.,Cell,2018-07-25T20:08:00,134,2,215-30,Massagué J,doi: 10.1016/j.cell.2008.07.001,,0001-07-25,,20495575,TGFbeta signalling: a complex web in cancer progression.,Nature reviews. Cancer,2018-06-01T20:10:00,10,6,415-24,Ikushima H et al,doi: 10.1038/nrc2853,,0001-06-01,,16788944,Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.,Journal of surgical oncology,2018-07-01T20:06:00,94,True,1951-06-01,Fukuchi M et al,,,0001-07-01,,12821112,Role of Smad4 (DPC4) inactivation in human cancer.,Biochemical and biophysical research communications,2018-07-11T20:03:00,306,4,799-804,Miyaki M et al,,,2018-07-11T08:04:00,,8752209,MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.,Cell,0001-08-23,86,4,543-52,Eppert K et al,,,0001-08-23,,23139211,"SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.",Cancer research,2018-01-15T20:13:00,73,2,725-35,Fleming NI et al,doi: 10.1158/0008-5472.CAN-12-2706,,0001-01-15,,21110833,Phosphorylated smad2 in advanced stage gastric carcinoma.,BMC cancer,2017-11-26T20:10:00,10,,652,Shinto O et al,doi: 10.1186/1471-2407-10-652,,0001-11-26,,12894231,"Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer.",Oncogene,2018-07-31T20:03:00,22,31,4889-97,Maliekal TT et al,,,0001-07-31,
